PHARMACOLOGY AND PHARMACOKINETICS OF EZETIMIBE AND SIMVASTATIN FOR DYSLIPIDEMIA

Journal Title: World Journal of Pharmaceutical Research - Year 2019, Vol 8, Issue 11

Abstract

Cardiovascular disease involves cardiovascular systems: heart, blood vessels, and blood circulation system. One of the main risks of cardiovascular disease is arteriosclerosis resulted from dyslipidemia in which LDL cholesterol increases. Simvastatin is one of the derivatives of Statins also known as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase used to reduce cholesterol. Ezetimibe reduces cholesterol by working in the brush border located in the small intestine to block the reabsorption of cholesterol. As a result, less cholesterol is taken to the liver. The combination of ezetimibe (10mg) and simvastatin (10, 20, 40 mg) is effective in reducing the level of LDL-C, so it can be used to cure dyslipidemia suffered by patients with an increased cardiovascular disease risk.

Authors and Affiliations

Irma Novrianti

Keywords

Related Articles

KATIBASTI: A REVIEW

The procedure of applying heat to the sacral or lumbar region by retaining warm medicated oil within a specially formed frame at this area is popularly known as ‘Katibasti’. Basti generally refers to the administration o...

ASSESSMENT OF THE KNOWLEDGE, ATTITUDE, AND PRACTICE OF SUDANESE COMMUNITY PHARMACISTS, IN KHARTOUM STATE, ABOUT POSITIVE LIFE STYLE CHANGES, NUTRITION AND DIETARY SUPPLEMENTS

Background: Based on the new responsibilities advised by pharmaceutical care practice and accepted by pharmacists, they have to counsel customers on positive life style changes, food, and its nutritional elements. Main s...

EVALUATION THE EFFECT OF REINFORCEMENT MATERIALS AND THERMAL CYCLE TREATMENT ON SOME MECHANICAL AND PHYSICAL PROPERTIES OF SOFT LINER

Back ground: Resilient denture liners may be advantageous for patients who are capable of delivering a relatively heavy occlusal load to unfavorable denture-bearing tissues. Without a resilient liner, surface hardness of...

OCULAR SURFACE AND GLAUCOMA MEDICAL THERAPY

Purpose: To compare the impact on the ocular surface of glaucomatous patients under monotherapy by latanoprost, tafluprost, bimatoprost and bimatoprost/timolol 0.50% fixed combination. Patients and Methods: This is a sin...

A REVIEW ON YASHTIMADHU (GLYCYRRHIZA GLABRA) – AN EXCELLENT MEDICINAL PLANT FOR THE FUTURE

Yashtimadhu (Glycyrrhiza glabra) a potent medicinal herb which was described in ayurveda, cures varieties of ailments from simple cough to more complex diseases like hepatitis, cancer etc. It is reported to contain impor...

Download PDF file
  • EP ID EP673249
  • DOI -
  • Views 137
  • Downloads 0

How To Cite

Irma Novrianti (2019). PHARMACOLOGY AND PHARMACOKINETICS OF EZETIMIBE AND SIMVASTATIN FOR DYSLIPIDEMIA. World Journal of Pharmaceutical Research, 8(11), 88-100. https://europub.co.uk/articles/-A-673249